跳至主要内容
临床试验/NCT03006536
NCT03006536已完成不适用

Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial

Zealand University Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
International Index of Erectile Function (IIEF)

研究概览

简要总结

The proposed mechanism of action for LI-ESWT in ED is that it improves endothelial function and triggers angiogenesis through induction of local growth factors and endothelial nitric oxide synthase. The literature generally confirms that LI-ESWT is safe and cohort studies investigating the clinical effects have been encouraging. Meanwhile, randomized trials have shown contradictory results. Thus, a randomized trial in 67 PDE5-I responders showed statistically greater improvements in the Erectile Function Domain of the International Index of Erectile Function (IIEF) with active LI-ESWT treatment compared to a sham treatment (p=0.032).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 18-70 years
  • A history of erectile dysfunction for >6 months
  • IIEF-ED score < 25
  • In a stable heterosexual relationship for at least 6 months
  • Willingness to attempt sexual intercourse at least twice per week during the study and follow-up

排除标准

  • Psychogenic ED as assessed by a standardized interview (attachment 2)
  • Known psychiatric illness
  • Neurological disease (including Parkinson's disease, Multiple sclerosis, spinal cord injury, and a history of stroke)
  • Traumatic nerve injury
  • Previous pelvic surgery or radiation
  • Heart disease in the form of unstable angina, NYHA class >II heart failure, uncontrolled arrhythmia, or significantly symptomatic and/or severe valvular disease
  • Endocrine disease including hypogonadism (total testosterone <12 nmol/l)
  • Insulin dependent or uncontrolled diabetes mellitus
  • Dependence on erectogenic aids other than PDE5-Inhibitors
  • Use of medications which have been shown to interfere with erections
  • Use of anticoagulant medications other than low dose aspirin
  • Active cancer
  • A diagnoses of Peyronie's disease and/or prior occurrence of priapism
  • Alcohol abuse (more than 21 containers of alcohol per week)

结局指标

主要结局

International Index of Erectile Function (IIEF)

时间窗: 1 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nessn Azawi

Chief Urologist

Zealand University Hospital

研究点 (2)

Loading locations...

相似试验

Low-Intensity Extracorporeal Shock Wave Treatment... | 临床试验